OneSource Specialty Pharma Limited (NSE:ONESOURCE)

NSE:ONESOURCE Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Revenue	14,449	1,719	387.14
Revenue Growth (YoY)	740.43%	344.07%	-
Cost of Revenue	4,350	852.13	336.43
Gross Profit	10,098	867.06	50.71
Selling, General & Admin	2,153	825.5	749.29
Other Operating Expenses	3,280	844.61	808.7
Operating Expenses	8,172	2,433	2,215
Operating Income	1,926	-1,566	-2,164
Interest Expense	-1,663	-853.99	-401.06
Interest & Investment Income	-	17.65	14.67
Currency Exchange Gain (Loss)	-	-5.75	-91.59
Other Non Operating Income (Expenses)	174.74	-38.97	-73.21
EBT Excluding Unusual Items	437.79	-2,447	-2,715
Merger & Restructuring Charges	-1,108	-	-
Gain (Loss) on Sale of Investments	-	7.57	1.15
Gain (Loss) on Sale of Assets	-	-58.08	-
Asset Writedown	-	-1,159	-1,451
Pretax Income	-670.66	-3,657	-4,156
Income Tax Expense	-497.85	-	-
Earnings From Continuing Operations	-172.81	-3,657	-4,156
Earnings From Discontinued Operations	-6.9	-254.68	-3,842
Net Income	-179.71	-3,912	-7,998
Net Income to Common	-179.71	-3,912	-7,998
Shares Outstanding (Basic)	110	42	40
Shares Outstanding (Diluted)	110	42	40
Shares Change (YoY)	165.37%	4.34%	-
EPS (Basic)	-1.63	-94.15	-200.87
EPS (Diluted)	-1.63	-94.15	-200.87
Free Cash Flow	-1,960	-1,710	-2,068
Free Cash Flow Per Share	-17.78	-41.15	-51.93
Gross Margin	69.89%	50.43%	13.10%
Operating Margin	13.33%	-91.09%	-558.99%
Profit Margin	-1.24%	-227.53%	-2066.00%
Free Cash Flow Margin	-13.57%	-99.45%	-534.07%
EBITDA	4,665	-803.03	-1,507
EBITDA Margin	32.29%	-46.71%	-
D&A For EBITDA	2,739	762.95	656.8
EBIT	1,926	-1,566	-2,164
EBIT Margin	13.33%	-91.09%	-
Revenue as Reported	14,623	1,761	414.06
Advertising Expenses	-	5.04	10.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.